DUACTIVE Trademark

Trademark Overview

On Friday, August 16, 2019, a trademark application was filed for DUACTIVE with the United States Patent and Trademark Office. The USPTO has given the DUACTIVE trademark a serial number of 88581361. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Meda Pharmaceuticals Inc.. The DUACTIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of allergies
duactive

General Information

Serial Number88581361
Word MarkDUACTIVE
Filing DateFriday, August 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of allergies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMeda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 5 GRANTED
Wednesday, August 17, 2022SOU EXTENSION 5 FILED
Wednesday, August 17, 2022TEAS EXTENSION RECEIVED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 4 GRANTED
Friday, February 18, 2022SOU EXTENSION 4 FILED
Tuesday, April 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 22, 2022NOTICE OF REVIVAL - E-MAILED
Monday, March 21, 2022EXTENSION RECEIVED WITH TEAS PETITION
Monday, March 21, 2022PETITION TO REVIVE-GRANTED
Monday, March 21, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, March 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2021SOU EXTENSION 3 GRANTED
Friday, August 13, 2021SOU EXTENSION 3 FILED
Friday, August 13, 2021TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 2 GRANTED
Thursday, February 11, 2021SOU EXTENSION 2 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020SOU EXTENSION 1 GRANTED
Wednesday, August 12, 2020SOU EXTENSION 1 FILED
Wednesday, August 12, 2020TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019ASSIGNED TO EXAMINER
Tuesday, September 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2019NEW APPLICATION ENTERED

Related Keywords

duactive allergies treatment pharmaceuticals